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ABSTRACT Mutagenesis and single-channel kinetic analysis were used to investigate the roles of four acetylcholine
receptor channel (AChR) residues that are candidates for interacting directly with the agonist. The EC50 of the ACh
dose-response curve was increased following -subunit mutations Y93F and Y198F and -subunit mutations D175N and
E184Q. Single-channel kinetic modeling indicates that the increase was caused mainly by a reduced gating equilibrium
constant () in Y198F and D175N, by an increase in the equilibrium dissociation constant for ACh (KD) and a reduction in
 in Y93F, and only by a reduction in KD in E184Q. This mutation altered the affinity of only one of the two binding sites
and was the only mutation that reduced competition by extracellular K. Additional mutations of E184 showed that K
competition was unaltered in E184D and was virtually eliminated in E184K, but that neither of these mutations altered the
intrinsic affinity for ACh. Thus there is an apparent electrostatic interaction between the E184 side chain and K (1.7kBT),
but not ACh. The results are discussed in terms of multisite and induced-fit models of ligand binding to the AChR.
INTRODUCTION
Nicotinic acetylcholine receptors (AChRs) are ion channels
that are activated by cationic ligands such as acetylcholine
(ACh) and tetramethylammonium (TMA). In adult muscle
AChRs are pentamers with the subunit composition 2,
and each -subunit houses, in part, an agonist binding site
located 30 Å above the membrane surface (Unwin, 1993;
Valenzuela et al., 1994).
Electron crystallographic images of Torpedo AChRs sug-
gest that each putative binding site is surrounded by three
helical segments that twist when the channel opens (Unwin,
1995). Affinity labeling and functional studies also suggest
that three regions of the -subunit (residues 86–93, 148–
153, and 190–198) participate in agonist binding (Devillers-
Thiery et al., 1993). Certain aromatic amino acids (W86,
Y93, W149, Y151, Y190, and Y198) and cysteines (C192
and C193) are labeled by the site-directed ligands DDF
(Dennis et al., 1988; Galzi et al., 1990), nicotine (Middleton
and Cohen, 1991), or lophotoxin (Abramson et al., 1989).
Mutations of -subunit tyrosines at positions 93, 90, and
198 reduce the affinity of the AChR for agonists (O’Leary
and White, 1992; Tomaselli et al., 1991; Sine et al., 1994;
Nowak et al., 1995; Chen et al., 1995), whereas a G-to-S
mutation of -subunit residue 153 slows the agonist disso-
ciation rate constant and causes a slow channel congenital
myasthenic syndrome (Sine et al., 1995).
There is substantial evidence that the binding pockets are
not confined to the -subunits. In Torpedo, the two sites
have distinct affinities for D-tubocurarine, a competitive
antagonist of nicotinic receptors (Sine and Taylor, 1980).
This ligand labels both the - and -subunits (Pedersen and
Cohen, 1990). Further evidence of non--subunit participa-
tion in agonist binding comes from cross-linking studies
that reveal two acidic residues in the -subunit (D180 and
E189) that alter the apparent affinity for ACh and have been
proposed to interact directly with the quaternary amine
moiety of ACh (Czajkowski and Karlin, 1991; Czajkowski
et al., 1993). There is similar evidence that negatively
charged residues in the -subunit interact electrostatically
with the agonist molecule (Martin et al., 1996).
These studies suggest the transmitter binding sites are
generated by residues in the  and the adjacent subunits
(Blount and Merlie, 1989; Pedersen and Cohen, 1990; Sine
and Claudio, 1991; Prince and Sine, 1996; Tsigelny et al.,
1997; for a review see Karlin and Akabas, 1995). This view
is supported by electron microscopic images that reveal
significant structural differences between the two binding
sites of the Torpedo AChR (Unwin, 1996). However, func-
tional studies of 2 mouse AChR show that the equi-
librium dissociation constant for small agonists such as ACh
are similar at the two binding sites (Akk and Auerbach,
1996; Wang et al., 1997; Salamone et al., manuscript sub-
mitted for publication); thus the relative influences of short-
range versus long-range interactions between non- resi-
dues and the ligand at its docking site remain to be
determined.
The binding of transmitter is not a simple diffusional
process because the association rate constant for TMA is
10 times slower than for larger molecules such as ACh
and carbamylcholine (Zhang et al., 1995). In GABAA re-
ceptor channels, smaller agonists also associate more slowly
than larger agonists (Jones et al., 1998). One explanation for
this behavior is that the binding pathway is an extended
structure (Unwin, 1993) and that an agonist experiences
energy barriers and wells along its trajectory from the bulk
solution to the ligand docking site. Alternatively, an ago-
nist-dependent conformational change in the protein may be
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required to stabilize the ligand at the docking site, and the
rate constants for this “induced fit,” rather than diffusion,
determine the apparent association rate constant.
Another salient feature of agonist association in AChR is
that inorganic cations such as Na and K compete with
ACh for access to the agonist binding site (Akk and Auer-
bach, 1996). Because of this competition, in 150 mM NaCl
the apparent ACh association rate constant is about half its
value in pure water. This raises the possibility that muta-
tions that alter the apparent affinity of the AChR do so by
interfering with ion competition, rather than by altering
ligand-protein interactions per se.
We have used site-directed mutagenesis and single-chan-
nel kinetic analysis to investigate the roles of four residues
(Y93, Y198, D175, and E184), all of which are can-
didates for interacting directly with the bound agonist based
on affinity labeling and functional studies. We have dis-
sected the effect of the mutations on single-channel dose-
response profiles into more fundamental components: equi-
librium and rate constants for AChR activation, and the
equilibrium inhibition constant and selectivity for monova-
lent cations. The results suggest that only one of these
residues, E184, determines the equilibrium dissociation
constant of inorganic cations (but not ACh) via a direct
electrostatic interaction. The results are discussed in terms
of different physical models for the binding of ligands to the
AChR transmitter binding site.
MATERIALS AND METHODS
Mouse AChR subunit cDNA (, , , ) was provided by Dr. Steve Sine,
who obtained the clones (originally from Dr. J. Merlie) from Drs. H. Lester
and N. Davidson. The genes were subcloned into CMV-based expression
vectors pRBG4 (Sine, 1993) or pcDNAIII (Invitrogen, San Diego, CA).
Mutant clones Y93W and Y198F were provided by Dr. Sine. The
remaining mutants (D175N, E181Q, E184Q, E184K, E184D) were
created using overlap polymerase chain reaction (Higuchi, 1990). The
“wild-type” -subunit had a mutation in the M4 segment, V433A. This
mutation has essentially no effect on the activation rate constants (Salam-
one et al., manuscript submitted for publication).
Human embryonic kidney (HEK) 293 cells were transiently transfected
by calcium phosphate precipitation (Ausubel et al., 1992). A total of 3.6 g
DNA/35-mm culture dish in the ratio 2:1:1:1 (:::) was used. The
medium was changed 24 h after transfection, and electrophysiological
recordings were started 48 h later.
Because some of the mutants we examined were in the -subunit, we
also examined the properties of channel formed when only the -, -, and
-subunits were expressed (Charnet et al., 1992). The expression levels of
such “-less” AChR were low, but in some cases single-channel currents
with the conductance properties of 2 AChR could be recorded. These
channels had very long open channel lifetimes and on this basis were
readily distinguishable from the -mutant AChR we examined. We con-
clude that all of the results presented in this study concern AChR having
the full complement of subunits.
Electrophysiological recordings were performed using the patch-clamp
technique in the cell-attached configuration (Hamill et al., 1981). The bath
solution was Dulbecco’s phosphate-buffered saline (in mM): 137 NaCl, 0.9
CaCl2, 2.7 KC, 1.5 KH2PO4, 0.5 MgCl2, 6.6 Na2HPO4 (pH 7.3). The
pipette solution contained (in mM) 142 KCl, 1.8 CaCl2, 1.7 MgCl2, 5.4
NaCl, 10 HEPES (pH 7.4). In experiments at low ionic strength, only the
concentration of KCl was varied. The interior of the pipette was held at
70 mV; assuming a reversal potential of 0 mV and a conductance of 70
pS, we estimate that the membrane potential was typically 100 mV. The
temperature was 22°C.
Details of the recording and analysis are described by Akk et al. (1996).
Briefly, clusters were elicited by using high concentrations of ACh (Sak-
mann et al., 1980). Open and closed intervals within clusters were detected
using a half-amplitude threshold crossing criterion (Sachs, 1983). Histo-
grams of closed and open interval durations were fitted by sums of
exponentials. Usually the predominant component of the closed interval
duration histogram represented the slowest intracluster component. Clus-
ters were defined as groups of openings separated by gaps that were shorter
than a critical duration. This duration was at least four times longer than the
time constant of the predominant component of intracluster closed intervals
and was never shorter than 5 ms. Clusters less than 100 ms in duration were
rejected from further analysis. The closed interval durations of intracluster
gaps were compiled and fitted by sums of exponentials to check the
validity of the cluster definition criterion. The inverse of the predominant
component of the open and closed intracluster closed interval distribution
was defined as the effective closing rate () and opening rate (),
respectively. Clusters were extracted from the original data file for further
processing.
The extracted clusters were idealized using the segmental k-means
algorithm (Qin et al., 1996a; program SKM) to obtain a list of idealized
currents. The analysis bandwidth was typically 10 kHz. To determine the
rate constants, interval durations were fitted (using a maximum likelihood
procedure) by their corresponding probability density functions, assuming
a Markov kinetic scheme (Qin et al., 1996; program MIL). The algorithm
used a first-order correction for missed events; the dead time was 20 s.
One scheme that was used to encode AChR activation was
C-|0
Ak1
k1
AC-|0
Ak2
k2
A2C^


A2O Model 1
where A is the agonist concentration, k1 and k2 are the agonist associ-
ation rate constants, k1 and k2 are the agonist dissociation rate constants,
 is the channel opening rate constant, and  is the channel closing rate
constant. In model 1, when the binding sites are equivalent, k1  2k2
and k2  2k1, and there are only four free parameters. In this case the
probability of being open within the cluster (Po) is described by an
equilibrium dissociation constant (KD  k/k) and a gating equilibrium
constant (  /). During the kinetic modeling,  was constrained to be
the maximum value of .
RESULTS
Single-channel currents and
dose-response curves
Fig. 1 shows example clusters and interval duration histo-
grams from wild-type and mutant AChR. In all of the
mutants, the open-channel lifetimes are shorter and the
closed-channel lifetimes are longer (at a given ACh con-
centration) than the wild type.
Dose-response curves are shown in Fig. 2, and the pa-
rameters are given in Table 1. For all mutants, the EC50 of
the Po versus concentration curve was larger than the wild
type. For D175N and Y93W the maximum Po was sig-
nificantly lower than the wild type. To determine the extent
to which the Po curves were influenced by changes in
cluster open and closed lifetimes, these parameters are plot-
ted as a function of the ACh concentration in Fig. 2, B and
C. The open-channel lifetime did not change with concen-
tration and was within a factor of 4 for all AChRs that were
examined. Thus the changes in the Po profiles arise mainly
from changes in rate constants that influence closed durations.
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The effective opening rate () is a complex function that
depends on all of the rate constants of model 1 except  and
that approaches  at high agonist concentrations. Fig. 2 C
shows that the EC50 of this parameter varied 100-fold
between wild-type and mutant AChRs, and that  was
substantially smaller in D175N and Y93W than in the
wild type. The results of fitting the  curves are given in
Table 1. Compared to the wild type, there was no detectable
change in  in E184Q, an approximately threefold reduc-
tion in Y198F, a 33-fold reduction in D175N, and a
130-fold reduction in Y93W.
Because we could not measure a saturation in  for
E184Q, we quantified the limiting value of  by using an
agonist that supports a slower opening rate constant, TMA,
and a mutant AChR, G153S. This mutation does not
substantially alter the channel opening rate constant but
facilitates the measurement of , because agonist dissocia-
tion is slowed, and the lifetime and number of sojourns in
the A2C state are increased (Sine et al., 1995). In G153S
E184Q AChR activated by TMA, we estimate  7374	
2069 s1 (mean 	 SD; three patches), which is similar to
the value of  for wild-type AChRs activated by TMA
(8150 s1; Akk and Auerbach, 1996). If we assume that the
effects of both mutations are independent of the nature of
the agonist, then this result suggests that the E184Q mu-
tation does not significantly alter the channel opening rate
constant when ACh is the agonist.
Kinetic modeling: equal binding sites
Rate constants governing receptor activation were deter-
mined by fitting the parameters of model 1 (i.e., assuming
equivalent transmitter binding sites) to a list of idealized
intracluster interval durations.  was constrained to be
the value obtained from fitting the  curve (Table 1), or in
the case of E184Q, 60,000 s1. The results are shown in
Table 2.
Y93W causes an almost 100-fold decrease in k. This,
along with a 10-fold decrease in k, is the basis for the
10-fold higher KD for ACh in this mutant. However, the
largest consequence of the Y-to-W mutation is a 130-fold
decrease in . In contrast,  was essentially unchanged.
Together, these rather dramatic effects on channel opening
and ligand binding result in a 70-fold shift in the EC50 of
the Popen dose-response curve (Fig. 2 A).
The Y198F mutation in the -subunit has a much more
modest effect on AChR activation. Both k and k are
reduced approximately twofold, with little net effect on KD.
However, the mutation both reduces  and modestly in-
creases , thereby lowering the gating equilibrium constant
10-fold. Although the 198 site has been proposed by
others (O’Leary and White, 1992; Sine et al., 1994) to
interact directly with ACh in the binding pocket, these
results indicate that the Y-to-F mutation mainly alters gat-
ing, and not binding, and is therefore not a good candidate
for making direct contact with agonist.
FIGURE 1 Single-channel current clusters from adult-type AChR. Open
and closed interval duration histograms are shown to the right. The [ACh]
was 50 M, except for Y93W, which was 2 mM ACh (membrane
potential100 mV, 22°C). The open intervals are shorter and the closed
interval are longer in the mutant AChR. The lower amplitude of the
Y93W currents is caused by channel block by ACh.
FIGURE 2 Dose-response curves. (A) The probability of being open
within a cluster (Popen). (B) The effective closing rate () is not dependent
on the [ACh]. (C) The effective opening rate (). The Po and  curves for
the mutant AChR are shifted to the right compared to the wild type. The
solid line is fit by Hill equation (see Table 1). Each symbol is one patch.
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D175 is homologous to residues in the - and -subunits
that have been proposed to interact directly with the posi-
tively charged nitrogen of ACh (Czajkowski et al., 1993).
Kinetic modeling indicates that the mutation D175N sig-
nificantly reduces both k and k, with essentially no
change in KD. This mutation also has a large effect on
gating, with a30-fold decrease in  and an approximately
twofold increase in . The relatively minor effect on the KD
consequent to the loss of charge at this position does not
support the hypothesis that this residue stabilizes the bound
ACh ligand via a direct electrostatic interaction. Rather, the
kinetic results suggest that this mutation decreases the mo-
bility of ACh between the bulk solution and the transmitter
docking site.
The E184Q mutation was also modeled assuming equiv-
alent transmitter binding sites and a channel opening rate
constant of 60,000 s1. The rate constant estimates (Table
2) indicate that the mutation modestly increases k and 
and substantially increases k, with the combined effect of
these alterations being a fourfold increase in the EC50 of the
Po profile.
Kinetic modeling: unequal binding sites
If the transmitter binding sites are generated by - and -
subunit pairs, then an -subunit mutation might be expected
to alter ACh association and dissociation at only one of the
two sites. To test this possibility, E184Q currents from four
patches (50 M ACh, 70 mV, 62,228 intervals) were
fitted using kinetic schemes that allow for unequal binding.
The results are shown in Fig. 3. Note that in these experi-
ments the membrane potential was 30 mV more depolarized
than in the previous experiments and that this degree of
depolarization increases the closing rate constant and re-
duces the gating equilibrium constant 1.6-fold (Auerbach
et al., 1996). As a basis for comparison, for these files the
log likelihood (LL) of the fit by model 1 (i.e., assuming
equal binding sites) and   60,000 s1 was 389,647.
First, model 1 was used after removing the constraints of
equal association and dissociation rate constants. We were
unable to fit the intervals of E184Q AChR using this
scheme (which had five free parameters); the rate constants
of the model would not converge. We hypothesize that this
TABLE 2 AChR activation rate constants
Receptor
k (M
1 s1)
(in 142 mM KCl)
 (M
1 s1)
(in pure water) k (s
1)  (s1)  (/) n
Wild type 111 259 18020	 422 1321 	 15 45 4
Y93W 1.3 3.0 2010	 141 1312 	 15 0.35 4
Y198F 44 97 9300 2459 4.5 4
D175N 8.5 18 1580	 67 3141 	 39 0.57 4
E184Q 260 396 75000* 1906 	 34 31 3
E184K 107 109 6057	 308 3456 	 39 2.2 4
E184D 41 137 3762	 235 4935 	 63 0.8 4
E184I — — — 1176 	 21 4.0 5
E184A — — — 1539 	 155 39 4
Rate constants for AChR activated by ACh (142 mM KCl,100 mV, 22°C), obtained by fitting model 1 (assuming equivalent binding sites) to intracluster
open and closed interval durations. k is the association rate constant in 142 mM KCl,  is the association rate constant in pure water computed from
k and the equilibrium inhibition constant for K
 (see Fig. 7), k is the dissociation rate constant,  is the closing rate constant (estimate from
single-channel modeling, except for E184I and E184A, which are the inverse of the mean open channel lifetime), and  is the ratio of the opening rate
constant (; Table 1) and . Values are 	SD. n is the number of patches.
* The rate constant was fixed during the optimization.
TABLE 1 Dose-response parameters of wild-type and mutant receptors
Receptor Po,max EC50 (M) nH  (s
1) EC50 (M) nH n
Wild type 0.96 	 0.04 28 	 3 1.8 	 0.3 60,000* 532 	 79 1.6 	 0.1 6
Y93W 0.21 	 0.01 1911 	 103 1.9 	 0.2 463 	 112 2532 	 805 1.9 	 0.3 4
Y198F 1.0 	 0.1 219 	 53 1.3 	 0.3 23400 	 8928 1754 	 846 1.3 	 0.1 5
D175N 0.41 	 0.1 289 	 59 2.1 	 0.6 1775 	 805 302 	 156 2.2 	 0.6 5
E184Q 0.86 	 0.1 82 	 17 1.9 	 0.7 60,000* 785 	 161 1.5 	 0.1 5
E184K 0.67 	 0.03 80 	 7 1.7 	 0.2 7762 	 1364 190 	 52 1.5 	 0.1 7
E184D 0.45 	 0.03 125 	 22 2.5 	 1.0 4128 	 1260 214 	 126 1.6 	 0.6 6
E184I 0.44 	 0.03 119 	 29 2.0 	 0.8 4991 	 635 217 	 68 1.5 	 0.3 5
E184A 0.95 	 0.01 43 	 2 1.8 	 0.3 60,000* 514 	 84 1.5 	 0.1 5
Dose-response parameters for AChRs activated by ACh (142 mM KCl, 100 mV, 22°C). The probability of being open within a cluster (Po) and the
effective opening rate () versus [ACh] profiles were fitted by the Hill equation, x  m/(1  (EC50/[ACh]
nH), where x is the response (Po or ), nH is
the Hill coefficient, and m is the maximum response (Po,max or ). The fitted curves are shown in Figs. 2 and 6. Values are 	 SD.
* Not obtained by fitting the  dose-response curve ( in E184Q, and A were assumed to be the same as in the wild type).
210 Biophysical Journal Volume 76 January 1999
was because in this mutant, sojourns in the A2C state are
both rare and brief and are largely undetected. As a conse-
quence, there were only two closed interval components in
the idealized record, and kinetic models with more than two
closed states could not be fitted.
We approached the problem of estimating the association
and dissociation rate constants for E184Q in two ways.
First, using model 1, we fixed  (60,000 s1) and k2
(150,000 s1) and allowed k1, k1, and  to be free
parameters. The results were (mean 	 SD): k1  128 	 5
M1 s1, k1  18,238 	 2247 s
1, k2  183 	 14
M1 s1, and   4784 	 29 s1. Allowing the binding
sites to have different rate constants greatly improved the fit
for the same number of free parameters (LL  389,751, or
a log likelihood ratio of 104). This result suggests that in the
E184Q mutant the equilibrium dissociation constants at the
two sites are significantly different. From the above rate
constants we calculate an equilibrium dissociation constant
for each site: Ka  142 M and Kb  819 M. From this
analysis we conclude that the difference in affinity between
the sites arises mainly from a 14-fold faster dissociation rate
constant at one site, which is presumably the mutated -
site.
We used another approach that did not require constrain-
ing k2 to a specific value. If the A2C state is vanishingly
brief, model 1 condenses to
C-|0
Ak1
k1
AC-|0
A*
*
A2 O Model 2
where
*	
Ak2
1
 k2/
and *	

1
 /k2
(1)
When model 2 was used without constraints (four free
parameters), the optimal rates (simultaneous fit to three
patches) were k1  104 	 3 M
1 s1, k1  19,924 	
2042 s1, *  66 	 6 s1, and *  3534 	 26 s1
(LL  389,754, or a log likelihood ratio of 107; the rate
constants for the fit to each patch are given in the legend of
Fig. 3). From these rate constants we estimate that Ka 192
M, which is similar to the wild type (160 M). From Eq.
1, to estimate the remaining rate constants, we need to
estimate the ratio /k2. Although we have assumed that
  60,000 s1, in this analysis we have no information
regarding the value of k2, other than it is significantly
greater than .
Although the equilibrium dissociation constants of the
two transmitter binding sites in wild-type AChRs are the
same, the association and dissociation rate constants may be
2.5 times faster at one site (Salamone et al., manuscript
submitted for publication). At the slow site, the association
rate constant is 110 M1 s1, and the dissociation rate
constant is 17,000 s1. These values are similar to k1
and k1 of E184Q AChR, which suggests that this -sub-
unit mutation specifically alters the fast binding site. We
therefore speculate that the properties of the slow binding
site are determined by the - and -subunits, and the prop-
erties of the fast binding site are determined by the - and
-subunits.
The effect of the E184Q mutation at the fast site can be
estimated if we assume that only the dissociation rate con-
stant is affected. In wild-type AChR, k at the fast site is
300 M1 s1 (Salamone et al., manuscript submitted for
publication). If the -subunit mutation only changes the
dissociation rate constant for this site, then from * and Eq.
1 we calculate that k at this site in E184Q AChRs is3.5
times faster than the channel opening rate constant, i.e., it is
210,000 s1.
From these considerations we hypothesize that the E-to-Q
mutation in the -subunit has a single effect, to increase the
dissociation rate constant approximately fivefold. As a con-
sequence, we estimate that in E184Q AChR the KD of the
- site is 160 M, and the KD of the - site is 800
M. Note that the shape of the Popen dose-response curve is
not sensitive to affinity differences of the binding sites, and
a fivefold difference in the equilibrium dissociation constant
would not cause a measurable deviation from the equal
binding site curve.
Effect of the ionic environment
Na and K compete with ACh for the transmitter binding
sites (Akk and Auerbach, 1996). As a consequence, the k
estimates are sensitive to the concentrations of these inor-
ganic cations in the extracellular solution, as well as to
FIGURE 3 Kinetic analysis of E184Q AChRs. One cluster and the
closed and open interval duration histograms are shown for three patches
(50 M ACh, 40 mV). The solid lines are drawn from the fitted rate
constants (	SD) of model 2. Top (43 clusters, 27,435 events): k1 
117 	 6 M1 s1, k1  16,464 	 3107 s
1, *  51 	 7 s1, * 
3276 	 32 s1. Middle (31 clusters, 8774 events): k1  93 	 8 M
1
s1, k1  13,730 	 3236 s
1, *  50 	 8 s1, *  3248 	 51 s1.
Bottom (31 clusters, 8774 events): k1  120 	 12 M
1 s1, k1 
26,831 	 8766 s1, *  84 	 28 s1, *  3694 	 84 s1. The rate
constants k1 and k1 are the same in both E184Q and wild-type AChRs,
suggesting that this mutation increases ACh dissociation (by about five-
fold) only from one transmitter binding site.
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mutations that influence the equilibrium constant for inhi-
bition (KI) by these ions. We therefore set out to determine
the effect of the binding site mutations on the KI for the
predominant extracellular cation, K.
This information is doubly useful. First, it indicates the
extent to which the salient residue interacts with inorganic
cations when they are bound to the receptor. Second, the KI
value can be used to correct the observed association rate
constants measured in 142 mM KCl, thereby allowing a
more accurate picture of the effect of the mutations with
regard to the ACh affinity per se.
Fig. 4 shows the effect of varying the concentration of
KCl in the patch pipette on k for ACh, estimated by kinetic
modeling (assuming equal binding sites). As the extracel-
lular KCl concentration increases, k decreases because K

and ACh compete for a site (or sites) in the binding path-
way. The results were fitted by
k	

1


KCl
KI
(2)
where  is the association rate constant for ACh in pure
water.
The fitted values of KI for the wild-type and mutant
AChRs are shown in Table 3. Of the four positions that were
examined, only the E184Q mutation had a significant
effect on the KI for K
, which increased by approximately
threefold. This result suggests that the E184 residue inter-
acts favorably with the inorganic cation binding site(s),
whereas the D175, Y93, and Y198 residues do not.
In wild-type AChRs, the KI for Cs
 is about three times
lower than that of K (Akk and Auerbach, 1996). We next
examined whether the E184Q mutation altered the ion
selectivity of the inorganic cation binding site. Fig. 5 shows
dose-response curves for both wild-type and E184Q AChR
in the presence of Na, K, and Cs. In wild-type AChR,
FIGURE 4 The ACh association rate constant versus the extracellular
concentration of KCl. The association rate constant was estimated by
single-channel kinetic analysis and was normalized to the extrapolated
value in pure water. Each symbol is the mean of one to five patches. As the
[KCl] increases, the ACh association rate decreases because of increased
competition. The [KCl] that reduces the ACh association rate constant by
half is the equilibrium inhibition constant for K (KI) (see Table 3).
TABLE 3 Equilibrium constants for K inhibition and
ACh dissociation
Receptor KI for K
 (mM)
KD for ACh (M)
(in 142 mM KCl)
D for ACh (M)
(in pure water)
Wild type 92 162 70
Y93W 109 1546 649
Y198F 79 211 75
D175N 157 186 98
E184Q 486 1011 783
E184K 1600 69 64
E184D 88 151 58
E184I — 114 88*
E184A — 416 320*
KI is the equilibrium inhibition constant for K
, KD is the equilibrium
dissociation constant for ACh in 142 mM KCl, and D is the equilibrium
dissociation constant for ACh in pure water. The values for wild type,
Y93W, Y198F, and D175N were estimated assuming equivalent bind-
ing sites (Eq. 2, Fig. 3); the values for the E184 mutants were computed
assuming distinct affinities for ACh (Eq. 4) and K (Eqs. 8 and 9) at the
two sites (see Fig. 8) and pertain only to the - transmitter binding site.
* Calculated assuming that these mutations had the same effect on KI as
E184Q, i.e., KI  486 mM.
FIGURE 5 Dose-response curves for wild-type and E184Q AChRs in
different ionic environments. (A) Po versus [ACh] for wild-type receptors.
The EC50 depends on the nature of the extracellular cation in the sequence
Na  K  Cs. This shift is due to different KI’s for each ion. (B) 
versus [ACh] curve for wild-type AChR. (C) Popen versus [ACh] for
E184Q receptors. The shift in EC50 is decreased, indicating that the
mutation has reduced the selectivity between inorganic cations. Each
symbol is one patch.
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the increased EC50 values in the presence of these ions is
caused by a reduction in k caused by increased ion com-
petition (Eq. 2). Fig. 5 C shows that the dose-response curve
of the E184Q mutant AChR is substantially less affected
by changes in the ionic composition of the extracellular
solution. We conclude that the E184Q mutation reduces
the discrimination between inorganic cations, which is con-
sistent with the proposal that this residue interacts with an
inorganic cation-binding site.
Estimating distinct equilibrium
dissociation constants
If the two binding sites (a and b) are independent but have
different equilibrium dissociation constants (Ka and Kb),
then the following kinetic scheme is appropriate for quan-
titative analysis:
where ACa is a receptor with only site a occupied, and ACb
is a receptor with only site b occupied. According to model
3,
Po	 KaKbA2 
 Ka
 KbA 
 1 
 1
1
(3)
or
Kb	
A2Po
1 1
A
 Ka
 A (4)
We define Ka to pertain to the - site and assume that this
value does not vary with the 184 side chain. Kb values can
be calculated for each patch from two experimental param-
eters, [ACh] and Po, and two equilibrium constants, 
(which is voltage dependent and is different for different
184 mutants) and Ka.
Kb can also be estimated from the dose-response param-
eters. From model 3,
Po,max	

1
  (5)
EC50	
Ka
 Kb
 Ka
 Kb2
 4KaKb 
 1
2 
 1
Note that for wild-type AChRs, where the binding sites have
equal affinities (Ka  Kb) and the gating process greatly
favors opening (  1), Eq. 5 simplifies to
EC50	
Kd
 . (6)
Rearranging Eq. 5,
Kb	
EC50
EC50 
 1 Ka
EC50
 Ka
. (7)
Finally, we must correct the Ka and Kb estimates for each
patch to account for competition between the agonist and
extracellular K. Because the - site is unaltered, we
assume that the relationship between Ka and [KCl] is the
same for all -subunit mutants:
Ka	 a1
 
KClKI,a  (8)
where KI,a is the equilibrium inhibition constant for K
 (92
mM) and a is the equilibrium dissociation constant for
ACh in pure water at the - site (70 M; Akk and Auer-
bach, 1996). Kb, like Ka, will vary with the extracellular K
,
but KI,b and b may differ for each -subunit mutation.
Mutations to E184: ACh and K affinity
Fig. 6 shows dose-response curves of AChRs with E, Q, D,
and K side chains at 184. Dose-response parameters for I
and A mutants are given in Table 1. Compared to the wild
type, the D, K, and I substitutions increase the EC50 and
FIGURE 6 E184 mutations and ACh affinity. (A) Popen versus [ACh].
All of the mutations increase the EC50. The maximum Popen is significantly
lower in the D, K, and I mutants. (B) The effective opening rate versus
[ACh]. The maximum effective opening rate is lower in the K, D, and I
mutants. The solid lines are fits by the Hill equation (Table 1). Each
symbol is one patch.
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lower the maximum of the Po curve. The effect of varying
the extracellular [KCl] on the ACh association rate constant
(estimated by single-channel modeling) is shown in Fig. 7.
To determine the consequence of the mutation on both
ACh and K affinity, specifically at the - site, for each
patch Kb values were computed by combining Eqs. 4 and 8.
The results are plotted as a function of the extracellular
[KCl] in Fig. 8. These values were fitted by
Kb	 b1
 
KClKI,b  (9)
The fitted values of KI,b and b for different 184 side
chains are given in Table 3.
First, we consider the KI,b values, which reflect the effect
of the mutations on the affinity for K. Substitution of a
positively charged lysine changed the net charge on the
residue by2 and essentially eliminated the competition by
K. Substitution of a neutral glutamine changed the net
charge by 1 and reduced the affinity of the receptor for
K by about fivefold. Substitution of a negatively charged
aspartate did not change the net charge and did not change
the affinity of the receptor for K. This is a logical pro-
gression that suggests that the 184 side chain interacts
electrostatically with K at a site that competes with ACh.
From the E184Q mutation we estimate that the strength of
this interaction is 1.7kBT/e.
We next consider the b values, which reflect the effect of
the mutation on the intrinsic affinity (i.e., in the absence of
K competition) of the - binding site for ACh. Recall that
in wild-type AChR, E184 is a negatively charged gluta-
mate and b  70 M. b values were not measured for E184I and E184A mutants. To estimate the intrinsic af-
finity (in pure water) of these mutants for ACh, we assumed
that the KI,b value was the same as in E184Q. The results
are given in Table 3. Replacement of the negatively charged
E with a neutral Q or A increased the equilibrium dissoci-
ation constant by more than 10-fold. However, replacement
with either a negatively charged D, a positively charged K,
or a neutral I had essentially no effect on the affinity of the
receptor for ACh. This pattern of effects is not consistent
with a simple electrostatic interaction between the 184 side
chain and ACh.
The effects of these mutations on gating are shown in
Table 1. The channel opening rate constant was essentially
unaltered by the Q and A substitutions, but was significantly
reduced by K, D, and I mutations.
DISCUSSION
Mutations of putative binding site residues
We have examined mutations of four putative AChR bind-
ing site residues (Y93, Y198, D175, and E184). Pre-
vious studies had shown that mutation of these residues (or
their homologs) resulted in an increase in the EC50 of
normalized dose-response or binding curves. Here we have
attempted to account for the observed changes in the dose-
response curves in terms of more mechanistic properties of
FIGURE 7 E184 mutations and K affinity. Increasing the extracellu-
lar [KCl] slows the apparent ACh association rate constant, estimated by
single-channel modeling, assuming equivalent binding sites. The K con-
centration that slows association by twofold is the equilibrium inhibition
constant (KI) for K
 (see Table 3). Substitution of a positively charged
lysine greatly lowers the affinity of the receptor for K.
FIGURE 8 Effect of the 184 side chain on ACh and K affinities at the
- binding site. The equilibrium dissociation constant for ACh at the -
site (Kb) is plotted versus the extracellular concentration of KCl. The
values are the equilibrium inhibition constant for K and the equilibrium
dissociation constant for ACh in pure water obtained from fitting by Eq. 9
(solid line; see Table 3). The affinity for K was roughly equivalent with
the acidic D and E side chains, about five times lower with the neutral Q
side chain, and nearly 20 times lower with the positive K side chain. This
pattern is consistent with a direct electrostatic interaction between E184
and K. The affinity for ACh was similar for the E, D, and K side chains,
but was more than 10 times lower for the Q side chain. This pattern
suggests that the equilibrium dissociation constant for ACh is not deter-
mined by an electrostatic interaction with E184.
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the AChR, i.e., the equilibrium and/or rate constants for
ACh binding, channel gating, and competitive inhibition by
extracellular K.
E184Q specifically lowered the affinity for ACh without
changing the channel gating reaction. Because this mutation
was not in the -subunit, only one of the two binding sites
was affected, presumably the one formed by the - and
-subunits. The 10-fold decrease in affinity (in pure wa-
ter) caused by this mutation translates to a destabilization of
bound ACh by 2.3kBT. This mutation similarly decreased
the affinity of the receptor for extracellular K by about
fivefold (1.7kBT). E184 remains a candidate residue for
interacting directly with AChR ligands.
D175N disrupted channel gating, mainly by lowering
the channel opening rate constant. The affinities of both
binding sites were unchanged by this mutation, and the
10-fold increase in the EC50 of the dose-response curve was
completely accounted for by the nearly 80-fold decrease in
the gating equilibrium constant. These results argue against
the proposal that D175 interacts directly with the quater-
nary amine moeity of ACh or with bound K. It is likely
that the increase in the EC50 of the normalized binding
curve consequent to mutation of the homologous residue in
the -subunit (Czajkowski et al., 1993) is also attributable to
an effect on gating, rather than binding.
Y93W and D175N, and to a lesser extent Y198F,
slowed both ACh association and dissociation, i.e., they
decreased the ability of the agonist to move readily between
the bulk solution and the transmitter docking site. In
D175N and Y198F the effect on association and disso-
ciation was nearly symmetrical, so that the KD for ACh was
essentially unaltered. In Y93W there was a significant net
destabilization of the bound transmitter molecule (2.2kBT).
All of the mutations had little effect on the channel closing
rate constant, and Y93W and D175N, and to a lesser
extent Y198F, slowed the opening rate constant.
This constellation of effects—reducing the ACh associa-
tion and dissociation rate constants, slowing channel open-
ing, and hardly influencing channel closing—is shared by
two other binding site mutations, D200N (Akk et al.,
1996) and Y190F (Chen et al., 1995). This pattern is not
what would be expected from specifically disrupting a fa-
vorable interaction between the mutated residues and the
bound ACh molecule, where the mutation might be ex-
pected to increase k and KD, and to perhaps have relatively
little effect on . Rather, the results suggest that the muta-
tions (in particular, Y93W) cause a more delocalized
change in the structure of the binding pocket that compro-
mises both the mobility of the ligand into and out of its
docking site and the high speed of channel opening.
The mutations Y93W and Y198F also had no measur-
able effect on competition by extracellular K, which sug-
gests that these residues probably do not contribute to the
cation-binding site(s) or to other structures that influence
the access of K to this site.
Mutations of E184
Six side chains of 184 were examined: E, Q, D, K, I, and
A. Receptors with a K, E, D, or I side chain had approxi-
mately the same intrinsic affinity for ACh (i.e., in pure
water; Table 3), whereas substitution of a Q or an A in-
creased the ACh equilibrium dissociation constant by about
10-fold. The basis for this change in affinity is unclear, but
the fact that AChRs with a positive, negative, or neutral side
chain at E184 have the same affinity for ACh strongly
argues against an electrostatic interaction between the 184
side chain and ACh. With regard to channel gating, the
opening rate constant remained fast with E, Q, and A side
chains, but was significantly slowed upon substitution of a
K, D, or I. Of the residues we examined, only E supported
both a high affinity for ACh and efficient gating.
Mutations to 184 had substantial effects on competitive
inhibition by extracellular cations (Fig. 8; Table 3). The
affinity for K decreased20-fold when the side chain was
positive (K) and decreased by about fivefold when the side
chain was neutral (Q) compared to when it was negative (E
and D). The E-to-Q mutation also reduced the ionic selec-
tivity of the competition between Na, K, and Cs. These
results suggests that the E184 side chain determines, in
part, inorganic cation affinity and selectivity via a direct
electrostatic interaction. From the magnitude of the effects
we estimate that loss of a negative charge at residue 184
destabilizes K by 1.7kBT.
We can estimate the product of the charge separation
distance (d) and the dielectic constant () from Coulomb’s
law (Hille, 1992):
GKI in kBT	 545z/d in Å (10)
where z is the net change in the charge of residue E184.
From the E-to-Q mutation we estimate that d  320 Å. If
the dielectric at the surface of a protein is 40 (Laberge,
1998), then we estimate that the separation between the
carbonyl of E184 and K is 8 Å. This distance is in
rough accord with the observation that in barnase there is an
electrostatic interaction of 0.7kBT between surface resi-
dues separated by 12 Å (Loewenthal et al., 1993).
Physical models of binding
In this section we discuss physical models for equilibrium
binding of ACh and K to the - site. Our goal is to
account for the observation that K binding is influenced by
an electrostatic interaction with E184, whereas ACh
binding is not.
We can reject the simplest model of binding, where both
ligands directly compete for a single spot. In such a static,
single-site mechanism, the KD for ACh
 and the KI for K

are each simply the ratio of the dissociation and association
rate constants for each ligand. Given an electrostatic inter-
action with both cationic ligands, we would expect that
changing the charge of the 184 side chain would alter both
equilibrium constants. Whereas this was the case with the Q
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mutation, the K and D mutations only changed the affinity
for K. This simple physical model of binding does not
account for the results.
The second physical model we consider is motivated by
the structure of acetylcholinesterase, which shows that the
substrate must traverse a distributed binding domain (a
“gorge”) on its path from the bulk solution to its docking
site (Sussman et al., 1991; Radic et al., 1997). In addition,
in this enzyme occupancy of a peripheral anionic site im-
pedes substrate binding to the active center (Radic et al.,
1994). With regard to AChR, in this model we propose that
at each transmitter binding site there are multiple ligand
binding sites in series. Minimally, there would be an outer
site and a docking site. We assume that the trajectory of a
ligand from the bulk solution to the docking site requires
single filing. Thus ACh and K compete even if K
cannot penetrate to the docking site. In this model the outer
and docking sites could be physically separated.
If the occupancy of the outer site by ACh is brief, the
apparent rates for the agonist moving between the bulk
solution and the docking site (k and k) and the apparent
equilibrium dissociation constant for an agonist (KD) are
k	 k011
 k10k12
1
k	 k211
 k12k10
1
(11)
Kb	
k01k10
k12k21
where k01 is the rate constant for moving from the external
solution to the outer site, k10 is the rate constant for return-
ing to the solution from the outer site, k12 is the rate constant
for moving from the outer site to the docking site, and k21 is
the rate constant for moving from the docking site to the
outer site.
If the 184 side chain interacts electrostatically only with
the ligand that resides in the outer site, changing the charge
of this side chain will change the relative magnitude of k10
and k12. Thus for competitive inhibitors (like K
) that
occupy only the outer site, KI  k01/k10, and changing the
charge on 184 will change affinity in a predictable way,
increasing as the side chain becomes more positive. For
agonists (like ACh) that reach the docking site, KD is a
function of the ratio of the altered rate constants, and the
effects of changing the charge cancel. Therefore, according
to the static, multisite model, changing the charge in 184
will have no effect on the apparent equilibrium dissociation
constant for ACh. This model accounts for the observation
that E, Q, and K side chains have logical effects on KI in
terms of electrostatics but more erratic effects on the KD for
ACh.
A third physical model for ACh and K binding sites is
derived from the “induced-fit” model of enzymes (Ko-
shland, 1970; Bennett and Steitz, 1980; Fersht et al., 1988).
In this scheme there is only one site for which both ligands
compete. A conformational change induced by the presence
of an agonist switches this site between a resting, ultralow
affinity conformation (KD 1000 M) to one with a higher
affinity for agonists (KD  100 M for ACh
). Note that
this conformational change is distinct from, but perhaps
related to, the conformational change that constitutes chan-
nel gating, and that this higher affinity form is distinct from
the one that accompanies channel opening and desensitiza-
tion, where KD  0.05 M for ACh
 (Sine et al., 1995; see
Auerbach and Akk, 1998). When the binding site is in the
ultralow affinity form, the dissociation rate constant of
either K and ACh is fast and the ligand can freely
exchange with the bulk solution. The ligand only becomes
“bound” when the site assumes its higher affinity confor-
mation. ACh has bonds that rotate freely; thus the agonist,
too, may change its conformation as part of the “induced
fit”.
In this model, we propose that K can occupy the site but
cannot induce the conformational switch. Thus electrostatic
interactions between the 184 side chain and the site are
indeed manifest as a logical change in the KI for K
.
However, for agonists (i.e., ligands that induce the confor-
mation change), the kinetic and equilibrium equations for
this induced-fit model are identical to those for the two-site
model (Eq. 11), assuming that the conformational switching
rates are rapid and with the following changes in definition:
k12 is the rate constant for changing from the lower to higher
form, and k21 is the rate constant for the reverse process.
That is, if the charge on 184 influences only binding and
not the conformational switch, then we would detect the
electrostatic effect on the selectivity and equilibrium con-
stant for ionic competition, but not on the KD for the
agonist.
Another physical model that combines features of the
two-site and induced-fit schemes is the “conformational
gating” mechanism that has been proposed for substrate
binding to acetylcholinesterase (Zhou et al., 1998). In this
mechanism, to bind to the catalytic site the substrate must
first pass a barrier that rapidly fluctuates between open and
closed positions. This scheme, like the two-site and in-
duced-fit models, can be described by a two-barrier, one-
well energy model and can therefore account (via Eq. 11)
for the observation that the charge on the E184 side chain
differentially effects K and ACh equilibrium binding.
Our results do not allow us to distinguish between the
static, two-site, and induced-fit mechanisms for binding.
There is precedent for both models, and binding may in-
volve both passage through a distributed pathway as well as
conformational adjustments. However, certain consider-
ations lead us to favor the induced-fit hypothesis. First, if
outer and docking sites can be occupied simultaneously, the
multisite model predicts that the dissociation rate constant
for ACh will be slowed by external K. The evidence
indicates that this rate constant is independent of the exter-
nal K concentration (Akk and Auerbach, 1996). Second, in
the multisite model the protein is static, whereas in the
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induced-fit model there is a conformational change at each
binding site consequent to ligand-protein contact. Such a
conformational event has previously been proposed to ac-
count for the different voltage dependences of un-, mono-,
and diliganded AChR (Auerbach et al., 1996; see also
Auerbach, 1993). Third, the induced-fit model offers a
mechanism to account for the correlation between the ago-
nist association rate constant and the rate constant for chan-
nel opening for different agonists (Zhang et al., 1995) and
mutants. The conformational change that is the “induced
fit” may be graded and agonist dependent and may also
have the consequence of changing the nature of the transi-
tion state that separates open and closed channel structures.
Thus a weaker agonist (e.g., TMA) might contribute less
binding energy, leading not only to a higher KD but also to
a slower channel opening rate constant. The induced-fit
model offers an explanation for why affinity and efficacy
are correlated (Post and Ray, 1995).
SUMMARY
Despite the difficulty of making inferences about structure
from purely functional results, our experiments offer the
following general insights. Normalized dose-response and
binding curves are “macroscopic” in nature, and changes in
agonist binding, channel gating, and ion competition com-
bine to determine the shape and position of these profiles. A
mutation-induced change in the EC50 is not sufficient evi-
dence to conclude that there is a direct interaction between
the mutated residue and the agonist molecule. The param-
eter that provides the clearest measure of the effect of a
mutation on agonist affinity per se is the equilibrium disso-
ciation constant extrapolated to its value in pure water.
When the AChR is in its closed channel conformation, the
transmitter binding site is a delicate structure that is readily
disturbed by a variety of perturbations, including mutations
to residues that may be located at some distance from the
agonist docking site. Finally, we propose that binding is a
complex process that could involve multiple sites of inter-
action and/or conformational changes in both the ligand and
the protein.
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